Vaxart Inc (VXRT):企業の財務・戦略的SWOT分析

◆英語タイトル:Vaxart Inc (VXRT) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH406158FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Vaxart Inc (VXRT) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Vaxart Inc (Vaxart), formerly Aviragen Therapeutics Inc, is a clinical-stage pharmaceutical company that develops oral recombinant vaccines based on its proprietary oral vaccine platform, which uses state-of-the-art recombinant technology. The platform enables the company to develop oral versions of currently available vaccines, and design recombinant vaccines for new indications. Vaxart is developing prophylactic vaccine candidates for a range of infectious diseases, including norovirus infection, seasonal influenza, respiratory syncytial virus (RSV) infection, and coronavirus (COVID-19) disease. The company is also developing a therapeutic immune-oncology vaccine, which targets cervical cancer, and dysplasia caused by human papillomavirus (HPV). Vaxart is headquartered in San Francisco, California, the US.

Vaxart Inc Key Recent Developments

Feb 25,2021: Vaxart provides business update and reports fourth quarter and full year 2020 financial results
Jan 28,2021: Vaxart announces resignation of Steven Boyd and Keith Maher
Nov 12,2020: Vaxart reports third quarter 2020 financial results and provides business update
Oct 07,2020: Centaur Biopharmaceutical services announces expansion of manufacturing agreement with Vaxart for COVID-19 and other vaccine candidates
Sep 25,2020: VAXART investigation initiated by Former Louisiana Attorney General: Kahn Swick & Foti investigates the officers and directors of Vaxart – VXRT

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Vaxart Inc – Key Facts
Vaxart Inc – Key Employees
Vaxart Inc – Key Employee Biographies
Vaxart Inc – Major Products and Services
Vaxart Inc – History
Vaxart Inc – Company Statement
Vaxart Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Vaxart Inc – Business Description
Vaxart Inc – Corporate Strategy
Vaxart Inc – SWOT Analysis
SWOT Analysis – Overview
Vaxart Inc – Strengths
Vaxart Inc – Weaknesses
Vaxart Inc – Opportunities
Vaxart Inc – Threats
Vaxart Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Vaxart Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Vaxart Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Vaxart Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 25, 2021: Vaxart provides business update and reports fourth quarter and full year 2020 financial results
Jan 28, 2021: Vaxart announces resignation of Steven Boyd and Keith Maher
Nov 12, 2020: Vaxart reports third quarter 2020 financial results and provides business update
Oct 07, 2020: Centaur Biopharmaceutical services announces expansion of manufacturing agreement with Vaxart for COVID-19 and other vaccine candidates
Sep 25, 2020: VAXART investigation initiated by Former Louisiana Attorney General: Kahn Swick & Foti investigates the officers and directors of Vaxart – VXRT
Aug 27, 2020: Vaxart appoints Karen J. Wilson to its Board of Directors
Aug 06, 2020: Vaxart announces second quarter 2020 results
Jul 16, 2020: Norovirus gastroenteritis costs an estimated $10.6 Billion each year in the United States
Jul 13, 2020: Second Virus Wave fears create growing demand for testing, treatments and vaccine candidates
Jun 25, 2020: Vaxart signs Memorandum of Understanding with Attwill Medical Solutions Sterilflow
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Vaxart Inc, Key Facts
Vaxart Inc, Key Employees
Vaxart Inc, Key Employee Biographies
Vaxart Inc, Major Products and Services
Vaxart Inc, History
Vaxart Inc, Subsidiaries
Vaxart Inc, Key Competitors
Vaxart Inc, Annual Ratios
Vaxart Inc, Annual Ratios (Cont...1)
Vaxart Inc, Interim Ratios
Vaxart Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Vaxart Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Vaxart Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Vaxart Inc (VXRT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sumitomo Corp (8053):電力:M&Aディール及び事業提携情報
    Summary Sumitomo Corp (Sumitomo) is a multifaceted business enterprise. It operates various businesses such as metal products, transportation, construction systems, infrastructure, media, network & lifestyle retail, general products, real estate, financial services, logistics, mineral resources and …
  • Gazprom (GAZP):電力:M&Aディール及び事業提携情報
    Summary Gazprom is an integrated global oil and gas company. It carries out the exploration, production, transportation, storage, processing and marketing of natural gas, gas condensate and crude oil. The company also sells gas as a vehicle fuel and participates in the generation and marketing of he …
  • Aeon Co., Ltd.:企業の戦略・SWOT・財務情報
    Aeon Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aeon Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Globus Medical Inc (GMED):企業の財務・戦略的SWOT分析
    Globus Medical Inc (GMED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Novo Nordisk AS (NOVO B)-医療機器分野:企業M&A・提携分析
    Summary Novo Nordisk A/S (Novo Nordisk), a subsidiary of Novo A/S discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disorders and obesity. The company’s product …
  • Bracket Global LLC-製薬・医療分野:企業M&A・提携分析
    Summary Bracket Global LLC (Bracket Global) is pharmaceutical company that offers clinical research development services. It strives to bring together science, technology and service to provide superior clinical outcomes for pharmaceutical companies and patients. The company offers services such as …
  • BankUnited Inc:企業のM&A・事業提携・投資動向
    BankUnited Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BankUnited Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Skanska AB:企業の戦略・SWOT・財務分析
    Skanska AB - Strategy, SWOT and Corporate Finance Report Summary Skanska AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Huttig Building Products Inc:企業の戦略・SWOT・財務情報
    Huttig Building Products Inc - Strategy, SWOT and Corporate Finance Report Summary Huttig Building Products Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Delek Group Ltd:企業のM&A・事業提携・投資動向
    Delek Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Delek Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Verint Systems Inc. (VRNT):企業の財務・戦略的SWOT分析
    Verint Systems Inc. (VRNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Advanced Accelerator Applications SA (AAAP)-医療機器分野:企業M&A・提携分析
    Summary Advanced Accelerator Applications SA (AAA) is a healthcare products provider that offers molecular nuclear medicine and diagnostic and therapeutic products. The company’s lead product candidate comprises Lutathera, a lutetium-177 somatostatin analogue peptide that is used for the treatment o …
  • CAB Incorporated:企業の戦略的SWOT分析
    CAB Incorporated - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • EDF Luminus SA:企業の戦略的SWOT分析
    EDF Luminus SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • PetroEnergy Resources Corp (PERC):企業の財務・戦略的SWOT分析
    Summary PetroEnergy Resources Corp (PERC) is a diversified company that offers oilfield and energy services. The company’s services include upstream oil and gas exploration and development, power generation, and renewable energy development services, among others. It undertakes renewable energy proj …
  • Assertio Therapeutics Inc:企業の戦略・SWOT・財務分析
    Assertio Therapeutics Inc - Strategy, SWOT and Corporate Finance Report Summary Assertio Therapeutics Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Center Parcs (Holdings 1) Limited:企業の戦略・SWOT・財務情報
    Center Parcs (Holdings 1) Limited - Strategy, SWOT and Corporate Finance Report Summary Center Parcs (Holdings 1) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Calypso Biotech SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Calypso Biotech SA (Calypso) is a biopharmaceutical company that develops antibody therapies. The company provides pipeline products such as CALY-0001 and CALY-0002. Its CALY-0001 therapeutic antibody is used in the treatment of Crohn’s disease; and CALY-0002 a humanized monoclonal antibody …
  • TVEL Fuel Co:企業の戦略的SWOT分析
    TVEL Fuel Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Sernova Corp (SVA):製品パイプライン分析
    Summary Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company is developing Cell Pouch System, an implantable medical device, which offers a natural organ- …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆